GLOBAL PHARMACEUTICAL GIANT CHOOSES OFS OEE SOFTWARE

GLOBAL PHARMACEUTICAL GIANT CHOOSES OFS OEE SOFTWARE



The OFS vision is for all manufactured products to be better made, with less effort and less waste. OFS software is widely used across dozens of different industries to increase manufacturing efficiencies and manufacturing profits.


About OFS: (www.ofsystems.com)

OFS is an Australian company specialising in productivity and efficiency improvement software (OEE software) for global manufacturing industries. Tens of thousands of operators are using OFS technologies in dozens of industries. Customers of OFS include: Kraft/Cadbury, Coca-Cola Amatil, Electrolux, AstraZeneca, Heinz, Orora, Dulux Group, Unilever, Food Plastics Co, PACT Group, Labelmakers, Visy Industries, Murray Goulburn, Tatura, Sanitarium, HB Fuller, Standard Can and NCI.


MELBOURNE, VICTORIA, 19 Mar 2014 - Operations Feedback Systems (OFS) a leading provider of real time productivity improvement software, announced today that global biopharmaceutical company AstraZeneca will be deploying the OFS Software Suite in its Australian operations at the North Ryde manufacturing facility in Sydney.


AstraZeneca Australia commenced a 3 month trial of OFS in September 2013. Almost immediately, collaboration between operational areas and management began to improve. Significant gains in OEE (Overall Equipment Effectiveness) quickly followed and extending the OFS deployment to the rest of the facility became an obvious progression.


“What initially attracted us to OFS was their proven ability to implement their software suite quickly and with minimal fuss”, said Mr Paul Ives Operational Excellence and Strategy Manager, AstraZeneca Australia. “Within 5 weeks we were live and the results that followed over the 3 month trial were significant. Unplanned downtime and setup time reduced significantly, and our run speed increased all resulting in a 13% OEE improvement from month 1 to month 3. We have now approved the deployment of OFS to further key production lines over the course of 2014 and 2015.”


“AstraZeneca are a great example of a business determined to improve the feedback loop between the operational audience management”, said Mr. James Magee, National Sales Manager for OFS. “The improvement in performance during the trial was brilliant and we are looking forward to seeing this replicated on all future OFS monitored production lines at North Ryde.”


About AstraZeneca Australia: (www.astrazeneca.com.au)


AstraZeneca Australia (AZA), based in North Ryde, Sydney, is the second largest pharmaceutical company operating in Australia. AZA employ almost 1,000 people, are one of the country’s largest manufacturers of medicines and are a key exporter to over 30 international markets. Its North Ryde site manufactures 240 separate product lines, namely sterile respiratory and local anaesthetic products. Of the top twenty medicines used in Australia, five are made by AstraZeneca. AstraZeneca produce medicines in seven separate therapeutic areas including cancer, respiratory, cardiovascular, and neuroscience.

OFS - Colour on transparent (medium_no w

+61 3 8684 9859

1st Floor, 10 York Street

Richmond, VIC, 3121, Australia

linkedingrey.png